Physician profile
Isolda Tsapok
NPI 1194748533
$2,082.85
in general payments reported to CMS, 2019-2025
22 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $179 · 2021: $437 · 2022: $315 · 2023: $248 · 2024: $257 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $362.70 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $332.12 | 2019-2025 | Slynd |
| Abbvie INC. | $276.13 | 2019-2021 | |
| Organon LLC | $184.63 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $151.72 | 2023-2025 | Gemtesa |
| Pfizer INC. | $140.88 | 2021-2023 | |
| Lupin INC. | $97.90 | 2019-2020 | |
| Agile Therapeutics, INC. | $84.98 | 2021-2023 | Twirla |
| Scynexis, INC. | $71.60 | 2022 | |
| Myovant Sciences INC. | $63.68 | 2021-2022 | |
| Therapeuticsmd, INC. | $59.00 | 2019-2022 | |
| Davol INC. | $52.25 | 2019 | |
| Merck Sharp & Dohme LLC | $36.95 | 2020-2021 | |
| Evofem Biosciences, INC. | $31.77 | 2021-2023 | Phexxi |
| Shield Therapeutics INC | $22.41 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $20.89 | 2024 | Intrarosa, Femring |
| Vertical Pharmaceuticals, LLC | $20.00 | 2019 | |
| Urovant Sciences INC | $19.38 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.20 | 2019 | |
| Avion Pharmaceuticals | $13.48 | 2021 | |
| Phadia US INC. | $11.86 | 2022 | |
| Mayne Pharma Commercial LLC | $10.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isolda Tsapok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.